| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/04/1998 | EP0652967B1 Self-assembling replication defective hybrid virus particles |
| 02/03/1998 | US5714374 Genetically engineered viruses comprising human rhinovirus incorporated with chimeric regions derived from an orthomyxovirus, picornavirus, retrovirus, neoplasm, parasite or bacterium; vaccines; immunoassay |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | US5714316 Chimeric envelope proteins for viral targeting |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 01/29/1998 | WO1998003649A1 Constructs and complexes of cyclin e |
| 01/29/1998 | WO1998003635A1 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same |
| 01/27/1998 | US5712136 Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein |
| 01/27/1998 | US5712118 Vaccine for branhamella catarrhalis |
| 01/27/1998 | US5712092 Papillomavirus probe and process for in vitro diagnosis of papillomavirus infections |
| 01/27/1998 | US5712089 Proteins and infecting bacteria |
| 01/27/1998 | US5712086 Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions |
| 01/22/1998 | WO1998002561A1 Method of producing particles containing nucleic acid sequences in yeast |
| 01/22/1998 | WO1998002549A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | WO1998002530A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | WO1998002522A1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 01/22/1998 | WO1998002457A1 Subunit respiratory syncytial virus vaccine preparation |
| 01/22/1998 | WO1998002174A1 Selective adsorbent for binding retroviruses |
| 01/22/1998 | CA2259964A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 01/22/1998 | CA2257823A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/21/1998 | EP0819170A1 Retroviral vectors |
| 01/21/1998 | CN1170760A Improvements in sustainable cell line for production of Marek's Disease Vaccines |
| 01/20/1998 | US5709996 Self-assembling recombinant papillomavirus capsid proteins |
| 01/15/1998 | WO1998001582A1 Method for measuring viral infectivity |
| 01/15/1998 | WO1998001570A2 Mutated antibody-dependent infection enhancing domains of hiv |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/14/1998 | EP0817861A1 Gene transfer into the kidney |
| 01/14/1998 | EP0817860A1 Pseudotyped retroviral particles |
| 01/14/1998 | EP0817859A1 Novel recombinant dna vectors for gene therapy |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817836A1 Cell line and process for multiplying rabies viruses and their quantitative detection |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/13/1998 | US5707850 Using porous media; applying electricity |
| 01/08/1998 | WO1998000547A1 Ribonuclease resistant rna preparation and utilization |
| 01/08/1998 | WO1998000524A1 Method for producing recombinant adenovirus |
| 01/08/1998 | WO1998000166A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 01/08/1998 | WO1998000165A1 Porcine reproductive and respiratory syndrome vaccine |
| 01/08/1998 | DE19625188A1 System zur Herstellung von AAV-Vektoren System for the production of AAV vectors |
| 01/08/1998 | CA2258485A1 Ribonuclease resistant rna preparation and utilization |
| 01/08/1998 | CA2258158A1 Method for producing recombinant adenovirus |
| 01/07/1998 | EP0815873A1 Selective stabilization of proteins by binding to an immobilised affinity ligandduring viral |
| 01/07/1998 | EP0815239A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy |
| 01/07/1998 | EP0690920B1 Biological control agents containing mollusc toxins |
| 12/31/1997 | WO1997049826A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus |
| 12/31/1997 | WO1997049824A1 System for the production of aav vectors |
| 12/31/1997 | WO1997045009A3 Long-term shelf preservation by vitrification |
| 12/31/1997 | CN1169161A Attenuated viruses and method of making same |
| 12/31/1997 | CN1036838C Method for prepn. of vaccine |
| 12/30/1997 | US5703221 Stealth virus nucleic acids and related methods |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
| 12/29/1997 | EP0814089A2 Respiratory syncytial virus: vaccines and diagnostic assays |
| 12/29/1997 | EP0813606A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/24/1997 | CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 12/24/1997 | CN1168676A Materials for the production of nanometer structures and use thereof |
| 12/23/1997 | US5700680 Fusion proteins |
| 12/23/1997 | US5700679 Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity |
| 12/23/1997 | US5700470 Genetic engineered genome comprising a foreign gene and a promoter for gene expressing the foreign gene |
| 12/23/1997 | CA1339596C Viral expression inhibitors |
| 12/18/1997 | WO1997047739A1 Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens |
| 12/18/1997 | CA2257871A1 Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens |
| 12/17/1997 | EP0812359A1 Group o hiv-1, fragments of such viruses, and uses thereof |
| 12/16/1997 | US5698530 A vaccinia virus into which carcinoembryonic antigen gene is inserteted; induce an active immune response |
| 12/16/1997 | US5698446 Methods and compositions for inhibiting production of replication competent virus |
| 12/16/1997 | US5698443 Tissue specific viral vectors |
| 12/16/1997 | US5698433 Infecting the cell of culture with inflenza virus; adding protease |
| 12/16/1997 | US5698432 Producing inactivated whole virus by treating with general inactivating agent, deaggregating agent, nucleic acid inactivating agent, then stabilizing with crosslinking agent |
| 12/16/1997 | US5698431 Deficient in virion host shutoff function, profoundly attenuated in its ability to replicate at periphery and in the nervous system, and reactivate from latency |
| 12/16/1997 | US5698203 Attenuated viruse reactive with monoclonal antibody a27 |
| 12/11/1997 | WO1997046667A1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 12/11/1997 | WO1997046666A1 Modified small rna viruses |
| 12/11/1997 | WO1997038666A3 Sulfur gasification power plant |
| 12/11/1997 | CA2258907A1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 12/10/1997 | EP0811077A1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
| 12/10/1997 | EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 12/10/1997 | EP0811069A1 Chimeric adenoviral fiber protein and methods of using same |
| 12/10/1997 | EP0811057A1 Viral preparations, vectors, immunogens, and vaccines |
| 12/10/1997 | EP0638122B1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
| 12/09/1997 | US5695767 Live, attenuated rotavirus which stimulates antibody production |
| 12/09/1997 | US5695766 Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
| 12/04/1997 | WO1997045550A2 Mini-adenoviral vector |
| 12/04/1997 | WO1997045009A2 Long-term shelf preservation by vitrification |
| 12/04/1997 | CA2257148A1 Mini-adenoviral vector |
| 12/04/1997 | CA2256333A1 Long-term shelf preservation by vitrification |
| 12/03/1997 | EP0809704A1 Method for preparing a recombinant adenovirus genome |
| 12/03/1997 | EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 12/03/1997 | EP0597852B1 Swine pneumonia vaccine and method for the preparation thereof |
| 12/02/1997 | US5693762 Humanized immunoglobulins |
| 12/02/1997 | US5693761 Genetic engineering; complementarity zones |
| 12/02/1997 | US5693509 Adenovirus for delivering foreign DNA into higher eukaryotic cells |
| 11/27/1997 | WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor |
| 11/27/1997 | WO1997044444A1 Immortalized avian cell lines |
| 11/27/1997 | CA2256038A1 Immortalized avian cell lines |
| 11/27/1997 | CA2253874A1 Viral particles which are masked or unmasked with respect to a cell receptor |
| 11/26/1997 | EP0808905A2 Adenoviral vector for the transfer of human genes in vivo |
| 11/26/1997 | EP0808362A1 Herpes simplex virus mutants |